{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T08:49:54Z","timestamp":1780476594168,"version":"3.54.1"},"reference-count":62,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.clindermatol.2022.07.002","type":"journal-article","created":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T05:27:39Z","timestamp":1660714059000},"page":"676-685","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Autoimmune bullous diseases in skin of color"],"prefix":"10.1016","volume":"40","author":[{"given":"Ayodeji","family":"Ajayi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sruveera","family":"Sathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vesna","family":"Petronic-Rosic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2022.07.002_bib0001","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1001\/jamadermatol.2018.3114","article-title":"Association of demographic and socioeconomic characteristics with differences in use of outpatient dermatology services in the United States","volume":"154","author":"Tripathi","year":"2018","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.clindermatol.2022.07.002_bib0002","series-title":"Fitzpatrick\u2019s Dermatology in General Medicine","author":"Weinstock","year":"2008"},{"key":"10.1016\/j.clindermatol.2022.07.002_bib0003","first-page":"850","article-title":"Dermatologic conditions in skin of color: part I. Special considerations for common skin disorders","volume":"87","author":"Kundu","year":"2013","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.clindermatol.2022.07.002_bib0004","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.jaad.2020.06.041","article-title":"Representation of dark skin images of common dermatologic conditions in educational resources: a cross-sectional analysis","volume":"84","author":"Alvarado","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2022.07.002_bib0005","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.3389\/fimmu.2019.02219","article-title":"A retrospective study of patient-reported data of bullous pemphigoid and mucous membrane pemphigoid from a US-based registry","volume":"10","author":"Lee","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.clindermatol.2022.07.002_bib0006","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3389\/fmed.2018.00220","article-title":"The growing incidence of bullous pemphigoid: overview and potential explanations","volume":"5","author":"Kridin","year":"2018","journal-title":"Front Med"},{"key":"10.1016\/j.clindermatol.2022.07.002_bib0007","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/bjd.19022","article-title":"Incidence, prevalence and mortality of bullous pemphigoid in England 1998\u20132017: a population-based cohort study","volume":"184","author":"Persson","year":"2021","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2022.07.002_bib0008","doi-asserted-by":"crossref","first-page":"450","DOI":"10.4103\/0378-6323.82398","article-title":"Bullous pemphigoid","volume":"77","author":"Khandpur","year":"2011","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.clindermatol.2022.07.002_bib0009","series-title":"Bullous Pemphigoid","author":"Baigrie","year":"2021"},{"key":"10.1016\/j.clindermatol.2022.07.002_bib0010","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.3390\/biom10101432","article-title":"Bullous pemphigoid: trigger and predisposing factors","volume":"10","author":"Moro","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.clindermatol.2022.07.002_bib0011","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1159\/000349982","article-title":"Concomitant bullous pemphigoid and dermatitis herpetiformis","volume":"226","author":"Schulze","year":"2013","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2022.07.002_bib0012","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1046\/j.1365-2133.2002.04835.x","article-title":"Guidelines for the management of bullous pemphigoid","volume":"147","author":"Wojnarowska","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2022.07.002_bib0013","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jaad.2003.12.033","article-title":"A patient with both bullous pemphigoid and epidermolysis bullosa acquisita: an example of intermolecular epitope spreading","volume":"51","author":"Fairley","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2022.07.002_bib0014","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1080\/1744666X.2016.1221343","article-title":"Clinical features and diagnosis of epidermolysis bullosa acquisita","volume":"13","author":"Vorobyev","year":"2017","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.clindermatol.2022.07.002_bib0015","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/bjd.20068","article-title":"Differences in the clinical presentation of bullous pemphigoid in patients with skin of colour and patients with white skin","volume":"185","author":"Shah","year":"2021","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2022.07.002_bib0016","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.jdcr.2020.08.035","article-title":"Autoimmune bullous disease in skin of color: a case series","volume":"6","author":"Tamazian","year":"2020","journal-title":"JAAD Case Reports"},{"key":"10.1016\/j.clindermatol.2022.07.002_bib0017","doi-asserted-by":"crossref","first-page":"36","DOI":"10.4103\/2229-5178.79862","article-title":"Perifollicular pigmentation in bullous pemphigoid: a diagnostic sign","volume":"2","author":"Kumaresan","year":"2011","journal-title":"Indian Dermatol Online J"},{"key":"10.1016\/j.clindermatol.2022.07.002_bib0018","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1001\/archdermatol.2009.205","article-title":"Mortality of bullous skin disorders from 1979 through 2002 in the United States","volume":"145","author":"Risser","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2022.07.002_bib0019","first-page":"29","article-title":"Targeting type 2 inflammation for treatment of bullous pemphigoid","volume":"2","author":"Seidman","year":"2020","journal-title":"J Dermatol Skin Sci"},{"key":"10.1016\/j.clindermatol.2022.07.002_bib0020","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.autrev.2014.01.047","article-title":"Diagnosis and classification of autoimmune blistering diseases","volume":"13","author":"Baum","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.clindermatol.2022.07.002_bib0021","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1590\/abd1806-4841.20199011","article-title":"Pemphigus vulgaris","volume":"94","author":"Porro","year":"2019","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.clindermatol.2022.07.002_bib0022","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/B978-0-7234-3691-1.00076-3","article-title":"Bullous diseases of the skin and mucous membranes","author":"Edhegard","year":"2013","journal-title":"Clin Immunol"},{"key":"10.1016\/j.clindermatol.2022.07.002_bib0023","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/j.jaad.2020.11.075","article-title":"Intraepithelial autoimmune blistering dermatoses: clinical features and diagnosis","volume":"84","author":"Montagnon","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2022.07.002_bib0024","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.3389\/fimmu.2019.01418","article-title":"Pemphigus: current and future therapeutic strategies","volume":"10","author":"Didona","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.clindermatol.2022.07.002_bib0025","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/jop.13052","article-title":"Clinical presentation and diagnostic delay in pemphigus vulgaris: a prospective study from Turkey","volume":"49","author":"Daltaban","year":"2020","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.clindermatol.2022.07.002_bib0026","doi-asserted-by":"crossref","first-page":"5","DOI":"10.29245\/2767-5092\/2021\/2.1137","article-title":"Pemphigus vulgaris in a Black patient: early recognition of disease saves lives","volume":"3","author":"Rodr\u00edguez-Santiago","year":"2021","journal-title":"J Dermatol Skin Sci"},{"key":"10.1016\/j.clindermatol.2022.07.002_bib0027","first-page":"367","article-title":"Oral pemphigus vulgaris: case report","volume":"25","author":"Arpita","year":"2015","journal-title":"Ethiop J Health Sci"},{"key":"10.1016\/j.clindermatol.2022.07.002_bib0028","series-title":"Vesicles and bullae. In: Lookingbill and Marks\u2019 Principles of Dermatology","first-page":"135","author":"Marks","year":"2019"},{"key":"10.1016\/j.clindermatol.2022.07.002_bib0029","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1046\/j.1523-1747.1998.00279.x","article-title":"The members of the plakin family of proteins recognized by paraneoplastic pemphigus antibodies include periplakin","volume":"111","author":"Mahoney","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2022.07.002_bib0030","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.clindermatol.2011.01.014","article-title":"IgA pemphigus","volume":"29","author":"Tsuruta","year":"2011","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2022.07.002_bib0031","article-title":"Azathioprine therapy and TPMT and NUDT15 genotype","author":"Dean","year":"2012","journal-title":"Medical Genetics Summaries. Bethesda, MD: National Center for Biotechnology Information;"},{"key":"10.1016\/j.clindermatol.2022.07.002_bib0032","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s12026-018-8986-7","article-title":"Pemphigus group: overview, epidemiology, mortality, and comorbidities","volume":"66","author":"Kridin","year":"2018","journal-title":"Immunol Res"},{"key":"10.1016\/j.clindermatol.2022.07.002_bib0033","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s12026-018-8986-7","article-title":"Pemphigus group: overview, epidemiology, mortality, and comorbidities","volume":"66","author":"Kridin","year":"2018","journal-title":"Immunol Res"},{"key":"10.1016\/j.clindermatol.2022.07.002_bib0034","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.det.2011.03.012","article-title":"Diagnosis and clinical features of pemphigus foliaceus","volume":"29","author":"James","year":"2011","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.clindermatol.2022.07.002_bib0035","unstructured":"Vukmer T, Hassani J, Ros A. Pemphigus foliaceus in an otherwise healthy 35-year-old male. Available at: https:\/\/cdn.ymaws.com\/www.aocd.org\/resource\/resmgr\/jaocd\/contents\/volume39\/39-13.pdf. Accessed Sep 9 2022."},{"key":"10.1016\/j.clindermatol.2022.07.002_bib0036","first-page":"105","article-title":"Pemphigus foliaceus: a case report and short review","volume":"78","author":"Khachemoune","year":"2006","journal-title":"Cutis"},{"key":"10.1016\/j.clindermatol.2022.07.002_bib0037","doi-asserted-by":"crossref","DOI":"10.1590\/1678-4685-gmb-2019-0369","article-title":"Beyond the HLA polymorphism: a complex pattern of genetic susceptibility to pemphigus","volume":"43","author":"Petzl-Erler","year":"2020","journal-title":"Genet Mol Biol"},{"key":"10.1016\/j.clindermatol.2022.07.002_bib0038","doi-asserted-by":"crossref","first-page":"e455","DOI":"10.1093\/milmed\/usy224","article-title":"Diagnosing pemphigus foliaceus: a rare blistering disease masquerading as a common dermatologic disorder","volume":"184","author":"Flood","year":"2019","journal-title":"Mil Med"},{"key":"10.1016\/j.clindermatol.2022.07.002_bib0039","series-title":"Pemphigus Foliaceus","author":"Lepe","year":"2021"},{"key":"10.1016\/j.clindermatol.2022.07.002_bib0040","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.jdcr.2020.02.040","article-title":"Bullous impetigo masquerading as pemphigus foliaceus in an adult patient","volume":"6","author":"Ligtenberg","year":"2020","journal-title":"JAAD Case Reports"},{"key":"10.1016\/j.clindermatol.2022.07.002_bib0041","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1590\/abd1806-4841.20143830","article-title":"The value of trichoscopy in the differential diagnosis of scalp lesions in pemphigus vulgaris and pemphigus foliaceus","volume":"89","author":"Sar-Pomian","year":"2014","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.clindermatol.2022.07.002_bib0042","first-page":"471","article-title":"Psoriasiform pemphigus foliaceus in an African American female: an important clinical manifestation","volume":"17","author":"Austin","year":"2018","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.clindermatol.2022.07.002_bib0043","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/1346-8138.12676","article-title":"Pemphigus in the Arab world","volume":"42","author":"Saleh","year":"2015","journal-title":"J Dermatol"},{"key":"10.1016\/j.clindermatol.2022.07.002_bib0044","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.jaad.2010.09.777","volume":"64","author":"Bolotin","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2022.07.002_bib0045","unstructured":"Merck Manual. Dermatitis herpetiformis. Available at: https:\/\/www.merckmanuals.com\/professional\/dermatologic-disorders\/bullous-diseases\/epidermolysis-bullosa. Accessed Sep 9, 2022."},{"key":"10.1016\/j.clindermatol.2022.07.002_bib0046","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.3389\/fimmu.2019.01290","article-title":"Dermatitis herpetiformis: novel perspectives","volume":"10","author":"Antiga","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.clindermatol.2022.07.002_bib0047","doi-asserted-by":"crossref","first-page":"21","DOI":"10.5070\/D32KW0R6BH","article-title":"Dermatitis herpetiformis: potential for confusion with linear IgA bullous dermatosis on direct immunofluorescence","volume":"14","author":"Van","year":"2008","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.clindermatol.2022.07.002_bib0048","first-page":"119","article-title":"Dermatitis herpetiformis in an African woman","volume":"30","author":"Machona","year":"2018","journal-title":"Pan African Med J"},{"key":"10.1016\/j.clindermatol.2022.07.002_bib0049","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2147\/CCID.S69127","article-title":"The diagnosis and treatment of dermatitis herpetiformis","volume":"8","author":"Antiga","year":"2015","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"10.1016\/j.clindermatol.2022.07.002_bib0050","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2174\/1871529X11313010008","article-title":"Glucose-6-phosphate dehydrogenase deficiency: disadvantages and possible benefits","volume":"13","author":"Manganelli","year":"2013","journal-title":"Cardiovasc Hematol Disord Drug Targets"},{"key":"10.1016\/j.clindermatol.2022.07.002_bib0051","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1016\/j.jid.2016.07.013","article-title":"Prevalence and age distribution of pemphigus and pemphigoid diseases in Germany","volume":"136","author":"H\u00fcbner","year":"2016","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2022.07.002_bib0052","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1046\/j.1365-2133.2002.04919.x","article-title":"Spectrum of subepidermal immunobullous disorders seen at the National Skin Centre, Singapore: a 2-year review","volume":"147","author":"Wong","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2022.07.002_bib0053","unstructured":"Ngan V. Epidermolysis bullosa acquisita. Available at: https:\/\/dermnetnz.org\/topics\/epidermolysis-bullosa-acquisita. Accessed Sep 9, 2022."},{"key":"10.1016\/j.clindermatol.2022.07.002_bib0054","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1038\/jid.2011.231","article-title":"Black patients of African descent and HLA-DRB1*15:03 frequency overrepresented in epidermolysis bullosa acquisita","volume":"131","author":"Zumelzu","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2022.07.002_bib0055","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1080\/1744666X.2016.1221343","article-title":"Clinical features and diagnosis of epidermolysis bullosa acquisita","volume":"13","author":"Vorobyev","year":"2017","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.clindermatol.2022.07.002_bib0056","series-title":"Epidermolysis Bullosa Acquisita","author":"Xiao","year":"2021"},{"key":"10.1016\/j.clindermatol.2022.07.002_bib0057","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.clindermatol.2011.03.008","article-title":"Linear immunoglobulin A bullous dermatosis","volume":"30","author":"Fortuna","year":"2012","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2022.07.002_bib0058","doi-asserted-by":"crossref","first-page":"145","DOI":"10.4103\/0019-5154.80406","article-title":"Linear IGA bullous dermatosis in Tunisian children: 31 cases","volume":"56","author":"Aida","year":"2011","journal-title":"Indian J Dermatol"},{"key":"10.1016\/j.clindermatol.2022.07.002_bib0059","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1365-2230.1991.tb00336.x","article-title":"Chronic bullous dermatosis of childhood\u2013clinical and immunological features seen in African patients","volume":"16","author":"Aboobaker","year":"1991","journal-title":"Clin Experimental Dermatol"},{"key":"10.1016\/j.clindermatol.2022.07.002_bib0060","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/j.0736-8046.2004.21521.x","article-title":"Chronic bullous dermatosis of childhood in north India","volume":"21","author":"Kanwar","year":"2004","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.clindermatol.2022.07.002_bib0061","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1111\/j.1365-4632.2006.02750.x","article-title":"Autoimmune subepidermal blistering diseases in Uganda: correlation of autoantibody class with age of patients","volume":"45","author":"Mulyowa","year":"2006","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2022.07.002_bib0062","first-page":"ic49","article-title":"Linear IgA bullous dermatosis","volume":"13","author":"Chen","year":"2013","journal-title":"Eplasty"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X2200089X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X2200089X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:19:57Z","timestamp":1760033997000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X2200089X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":62,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S0738081X2200089X"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2022.07.002","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoimmune bullous diseases in skin of color","name":"articletitle","label":"Article Title"},{"value":"Clinics in Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clindermatol.2022.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}